Beximco Pharmaceuticals PLC. announcements
297 Dhaka Stock Exchange announcements for Beximco Pharmaceuticals PLC. (BXPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (5).
- Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Beximco Pharmaceuticals PLC.' instead of 'Beximco Pharmaceuticals Limited' with effect from November 10, 2025. Other information (except name) will remain unchanged.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 4.10 for October-December 2024 as against Tk. 3.21 for October-December 2023; Consolidated EPS was Tk. 7.87 for July-December 2024 as against Tk. 6.69 for July-December 2023. Consolidated NOCFPS was Tk. 6.13 for July-December 2024 as against Tk. 10.01 for July-December 2023. Consolidated NAV per share was Tk. 111.35 as on December 31, 2024 and Tk. 101.11 as on December 31, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2025 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
- Regarding nomination or appointment of Independent Directors
Bangladesh Securities and Exchange Commission (BSEC) has appointed Independent Directors in the Board of the company. To view the information, please visit the following link: https://www.dsebd.org/Annexure/2024/BEXIMCO_BXPHARMA%20_SPCERAMICS_2025.pdf
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.